Evidence map›Paper›PMID 30949361›Full record

ArticleJournal of ophthalmology2019

Modeling a Telemedicine Screening Program for Diabetic Retinopathy in Iran and Implementing a Pilot Project in Tehran Suburb.

Sare Safi, Hamid Ahmadieh, Marzieh Katibeh, Mehdi Yaseri, Homayoun Nikkhah, Saeed Karimi, Ramin Nourinia, Ali Tivay, Mohammad Zareinejad, Mohsen Azarmina and 7 more

Abstract read
In one paragraph

Article in Journal of ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Telemedicine in ophthalmology in view of the emerging COVID-19 outbreak.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2020
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sare SafiOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hamid AhmadiehOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-8139-2661
Marzieh KatibehOphthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mehdi YaseriOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Homayoun NikkhahOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Saeed KarimiOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ramin NouriniaOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ali TivayNew Technologies Research Center, Amirkabir University of Technology, Tehran, Iran.
Mohammad ZareinejadNew Technologies Research Center, Amirkabir University of Technology, Tehran, Iran.
Mohsen AzarminaOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Alireza RamezaniOphthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Siamak MoradianOphthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad Hossein DehghanOphthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Narsis DaftarianOcular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Davood AbbasiIslamshahr Branch, Iranian Diabetes Society, Islamshahr, Iran.
Afshin Eshghi FallahOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Bahareh KheiriOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo model a community-based telescreening program for diabetic retinopathy (DR) in Iran and to implement a pilot project at the Iranian Diabetes Society (IDS) branch in a Tehran suburb.

methodsIn this mixed model study, a web application called the "Iranian Retinopathy Teleophthalmology Screening (IRTOS)" was launched. The educational course for DR screening was established for general practitioners (GPs). Registered patients in IDS branch were recalled for fundus photography; images were transferred to the reading center via IRTOS to be graded by GPs, and patients were informed about the results via mobile messaging. All images were independently reviewed by a retina specialist as the gold standard. Patients who required further assessment were referred to an eye hospital.

resultsOverall, 604 subjects with diabetes were screened; of these, 50% required referral. The sensitivity and specificity for diagnosis of any stage of DR by trained GPs were 82.8% and 86.2%, respectively, in comparison to the gold standard. The corresponding values for detecting any stage of diabetic macular edema (DME) were 63.5% and 96.6%, respectively.

conclusionsTelescreening was an effective method for detecting DR in a Tehran suburb. This screening model demonstrated its capacity for promoting diabetic eye care services at the national level. However, the sensitivity for detecting DME needs to be improved by modifying the referral pathway and promoting the skill of GPs.

Identifiers

PMID30949361
PMCPMC6425400

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.